Department of Orthopaedics and Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Adv Exp Med Biol. 2014;804:119-27. doi: 10.1007/978-3-319-04843-7_6.
The etiology of osteosarcoma (OS) remains enigmatic. Particular clinical and molecular patterns, observed with high frequency in OS, suggest that it results from some yet-to-be-discovered central driver. How else can biology generate such an aggressive, metastatic, genetically and chromosomally unstable malignancy with virtually no apparent precursor neoplasms that are partway along a disease path toward OS? With this conundrum as a backdrop, the discovery of every new native molecule with power to impact a cell's biology is usually quickly followed by a search to see if this type of molecule contains the key to unlock OS biology.
骨肉瘤(OS)的病因仍然是个谜。在 OS 中观察到的特定临床和分子模式表明,它是由一些尚未发现的核心驱动因素引起的。否则,生物学如何产生如此具有侵略性、转移性、遗传和染色体不稳定的恶性肿瘤,而实际上没有明显的前体肿瘤,这些肿瘤只是朝着 OS 疾病方向发展的一部分?在这个难题的背景下,每一种新的具有影响细胞生物学能力的天然分子的发现,通常都会很快随之进行搜索,以确定这种类型的分子是否包含了解锁 OS 生物学的关键。